Key Record Dates
| ClinicalTrials.gov Identifier: | NCT05075408 |
|---|---|
| Brief Title: | To Evaluate the Efficacy and Safety of Nemolizumab for 12 Weeks in Participants With Chronic Kidney Disease With Associated Moderate to Severe Pruritus (NemoCKDaP) |
| First Submitted : | September 30, 2021 |
| First Submitted that Met QC Criteria : | September 30, 2021 |
| First Posted : | October 12, 2021 |
| Last Update Submitted that Met QC Criteria : | April 5, 2024 |
| Last Update Posted : | April 9, 2024 |